A new rapid-fire technique for visualizing the structure of RNA in a cell could revolutionize the way scientists study this vital molecule. Unlike earlier techniques, which are labor-intensive and only yield the structure of one short strand of RNA at a time, the new process uses a parallel-processing approach to provide—for the first time—a global view of a species’ diverse RNA structures.

Marina Biotech, Inc., a leading RNAi-based drug discovery and development company, today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for patent application U.S. 11/745,003 broadly covering amphoteric liposomal formulations, including the Company's proprietary SMARTICLES(R) technology, for delivery of siRNAs and other compounds with therapeutic application.

It seems there is no limit to the Rockefeller Foundation’s ambitions to introduce anti-fertility compounds into either existing “health-services”, such as vaccines, or- as appears to be the case now- average consumer-products.

The National Institutes of Health this month set aside nearly $400,000 to fund three research projects focused on microRNAs and the heart, including one issued to a company aiming to develop an miRNA antagonist to prevent cardiac ischemia.

Alnylam Pharmaceuticals, Inc. /quotes/comstock/15*!alny/quotes/nls/alny (ALNY 13.63, -0.12, -0.87%) , a leading RNAi therapeutics company, announced today that it will make a total of 16 oral presentations at the American Chemical Society (ACS) Fall 2010 240th National Meeting & Exposition being held in Boston, Mass. from August 22-26, 2010.

Researchers from LC Sciences LLC and a collaboration of Universities(1) have established a porcine microRNAome, a complete catalog of all microRNAs expressed in the species Sus scrofa(2). MicroRNAs (miRNAs) are small regulatory RNA molecules known to control a wide array of cellular functions such as growth and development and whose dysregulation has been associated with disease.

Researchers at Tufts University School of Medicine and Tufts Medical Center have identified an RNA sequence that promotes increased numbers of specific microRNAs (miRNAs), molecules that regulate cell growth, development, and stress response.

Biology faces a basic paradox - life requires DNA to function, yet DNA evolved after life emerged. Now a study of modern bacteria has revealed what DNA's progenitor might be.